サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439544

血管ステント - 世界市場の考察、競合情勢、市場予測（2030年）

Vascular Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血管ステント - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血管ステントの市場規模は、2023年に133億1,000万米ドル、2030年までに210億1,000万米ドルに達し、2024年～2030年の予測期間にCAGRで7.90％の成長が見込まれます。血管ステント需要の増加は主に、アテローム性動脈硬化症、頸動脈疾患、末梢動脈疾患などの血管障害の有病率の増加によるものです。加えて、患者人口の低侵襲手術への選好の高まり、製品セグメントにおける技術の進歩、さまざまな血管ステントの承認などが、今後数年間の世界の血管ステント市場の促進要因の1つとなっています。

血管ステントの市場力学

血管ステント市場は、世界中の人々の間でさまざまな血管障害の負担が増加していることから、現在勢いを増しています。血管障害または血管疾患には、血管に影響を及ぼすあらゆる状態が含まれます。末梢動脈疾患（PAD）、頸動脈疾患、冠動脈疾患、脳卒中などは、世界の人々の間でより流行している血管障害です。例えば、2019年にWorld Stroke Organization（WSO）が明らかにした情報によると、世界全体で8,000万人以上の人々が脳卒中を経験しています。

また、オーストラリア政府の2022年のデータによると、2018年に国内で約3万8,600件の脳卒中が報告され、2017年～2018年にオーストラリアの成人の約6.2％が心臓、脳卒中に関連する1つ以上の疾患または血管疾患を有していました。同様の動向は、世界中のその他の国々でも見られる可能性が高いです。このように、世界中でさまざまな血管疾患の負担が増加していることから、血管ステントの需要が増加し、それによって予測期間の世界の血管ステント市場の成長が増大する見込みです。

さらに、患者の間で低侵襲手術に対する選好が高まっていることも、血管ステントの需要を高めると予測されています。バイパス手術に比べ、バルーン血管形成術や血管ステント留置術は侵襲性がはるかに低く、相対的に低リスクかつ低コストな処置であるためです。

さらに、企業が血管ステント製品の償還を受けることで、患者集団における血管ステントの普及が進み、今後数年間に血管ステント市場が拡大する可能性もあります。例えば2020年6月、インドの冠動脈心臓ステントのマーケットリーダーであるSMT（Sahajanand Medical Technologies Pvt Ltd）は、フランスのMinistry of Health and Public Affairsから、SupraflexとSupraflex Cruzの全額償還の確認を受けました。

このように、上記のすべての要因が絡み合い、今後数年間に血管ステント市場を後押しする可能性が高いです。

しかし、血管ステントに関連するリスクと、製品の厳格な規制承認プロセスが市場の成長を抑制する可能性が高いです。

さらに、前例のないCOVID-19パンデミックが、世界の血管ステント市場をその初期に減速させました。全国的なロックダウン、感染拡大を防ぐための選択手術の中止や拒否、国境を越えたロジスティクス制限によるサプライチェーンの混乱などが、血管ステント市場の成長鈍化につながる理由の一部です。しかし、2020年後半に世界中で数多くのCOVID-19ワクチンが承認され投与されたおかげで、医療サービスを含むさまざまな領域で活動の再開に大きな改善が見られ、それによって血管ステント市場の健全な回復期への道が開かれました。

血管ステント市場のセグメント分析

血管ステントタイプセグメントでは、薬剤溶出ステントが今後数年間に大きな市場シェアを占めると予測されます。薬剤溶出ステントに関連する主な利点は、これらのステントが安定冠動脈疾患においてベアメタルステント（BMS）と比較して経皮的冠動脈インターベンション（PCI）後のステント内再狭窄率を効率的に低下させることです。さまざまな研究から、薬剤溶出ステント（DES）は固有冠動脈病変においてBMSと比較して再狭窄率を70％以上減少させることが証明されています。そのため、現在ではPCI手術の際にDESを留置することが外科医に好まれていると考えられており、それによってDES血管ステントの需要が増加しています。

当レポートでは、世界の血管ステント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血管ステント市場レポートのイントロダクション

第2章 血管ステント市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 血管ステント市場の主な要因の分析

  • 血管ステント市場の促進要因
    • 世界中の人々の間でのさまざまな血管障害の有病率の上昇
    • 低侵襲手術に対する選好の高まり
    • 技術の進歩と血管ステントの発売
    • 老年人口の負担の増加
  • 血管ステント市場の抑制要因と課題
    • 血管ステントに関連するリスクと合併症
    • 厳格な規制当局の承認プロセス
  • 血管ステント市場の機会
    • 低中所得国が血管ステント市場にとっての大きな機会を持つ
    • 生体吸収性血管スキャフォールド（足場材）の機会

第5章 血管ステントのポーターのファイブフォース分析

第6章 血管ステント市場に対するCOVID-19の影響分析

第7章 血管ステント市場レイアウト

  • 製品タイプ別
    • 冠状動脈ステント
    • 末梢血管ステント
    • EVARステントグラフト
  • タイプ別
    • ベアメタルステント
    • 薬剤溶出ステント
  • 材料別
    • 金属
    • ポリマー
  • デリバリー方式別
    • バルーン拡張型ステント
    • 自己拡張型ステント
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 血管ステント：世界の企業シェア分析 - 主要3～5社

第9章 血管ステントの企業と製品のプロファイル

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • B. Braun Melsungen AG
  • Terumo Corporation
  • eucatech AG
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd
  • Vascular Concepts (SMT)
  • W. L. Gore & Associates, Inc.
  • Becton, Dickinson and Company.
  • ENDOLOGIX LLC.
  • Biosensors International Group, Ltd.
  • Lombard Medical
  • Translumina GmbH
  • JOTEC GmbH
  • iVascular
  • Cordis
  • Cook

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Vascular Stents Market
  • Table 3: Vascular Stents Market Analysis in Global (2021-2030)
  • Table 4: Vascular Stents Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Vascular Stents Market Analysis in Global by Type (2021-2030)
  • Table 6: Vascular Stents Market Analysis in Global by Material (2021-2030)
  • Table 7: Vascular Stents Market Analysis in Global by Mode of Delivery (2021-2030)
  • Table 8: Vascular Stents Market Analysis in Global by End User (2021-2030)
  • Table 9: Vascular Stents Market Analysis in Global by Geography (2021-2030)
  • Table 10: Vascular Stents Market Analysis in North America (2021-2030)
  • Table 11: Vascular Stents Market Analysis in North America by Product Type (2021-2030)
  • Table 12: Vascular Stents Market Analysis in North America by Type (2021-2030)
  • Table 13: Vascular Stents Market Analysis in North America by Material (2021-2030)
  • Table 14: Vascular Stents Market Analysis in North America by Mode of Delivery (2021-2030)
  • Table 15: Vascular Stents Market Analysis in North America by End User (2021-2030)
  • Table 16: Vascular Stents Market Analysis in North America by Country (2021-2030)
  • Table 17: Vascular Stents Market Analysis in the US (2021-2030)
  • Table 18: Vascular Stents Market Analysis in Canada (2021-2030)
  • Table 19: Vascular Stents Market Analysis in Mexico (2021-2030)
  • Table 20: Vascular Stents Market Analysis in Europe (2021-2030)
  • Table 21: Vascular Stents Market Analysis in Europe by Product Type (2021-2030)
  • Table 22: Vascular Stents Market Analysis in Europe by Type (2021-2030)
  • Table 23: Vascular Stents Market Analysis in Europe by Material (2021-2030)
  • Table 24: Vascular Stents Market Analysis in Europe by Mode of Delivery (2021-2030)
  • Table 25: Vascular Stents Market Analysis in Europe by End User (2021-2030)
  • Table 26: Vascular Stents Market Analysis in Europe by Country (2021-2030)
  • Table 27: Vascular Stents Market Analysis in France (2021-2030)
  • Table 28: Vascular Stents Market Analysis in Germany (2021-2030)
  • Table 29: Vascular Stents Market Analysis in the UK (2021-2030)
  • Table 30: Vascular Stents Market Analysis in Italy (2021-2030)
  • Table 31: Vascular Stents Market Analysis in Spain (2021-2030)
  • Table 32: Vascular Stents Market Analysis in Russia (2021-2030)
  • Table 33: Vascular Stents Market Analysis in Rest of Europe (2021-2030)
  • Table 34: Vascular Stents Market Analysis in Asia-Pacific (2021-2030)
  • Table 35: Vascular Stents Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 36: Vascular Stents Market Analysis in Asia-Pacific by Type (2021-2030)
  • Table 37: Vascular Stents Market Analysis in Asia-Pacific by Material (2021-2030)
  • Table 38: Vascular Stents Market Analysis in Asia-Pacific by Mode of Delivery (2021-2030)
  • Table 39: Vascular Stents Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 40: Vascular Stents Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 41: Vascular Stents Market Analysis in China (2021-2030)
  • Table 42: Vascular Stents Market Analysis in Japan (2021-2030)
  • Table 43: Vascular Stents Market Analysis in India (2021-2030)
  • Table 44: Vascular Stents Market Analysis in Australia (2021-2030)
  • Table 45: Vascular Stents Market Analysis in South Korea (2021-2030)
  • Table 46: Vascular Stents Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 47: Vascular Stents Market Analysis in Rest of World (2021-2030)
  • Table 48: Vascular Stents Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 49: Vascular Stents Market Analysis in Rest of World by Type (2021-2030)
  • Table 50: Vascular Stents Market Analysis in Rest of World by Material (2021-2030)
  • Table 51: Vascular Stents Market Analysis in Rest of World by Mode of Delivery (2021-2030)
  • Table 52: Vascular Stents Market Analysis in Rest of World by End User (2021-2030)
  • Table 53: Vascular Stents Market Analysis in Rest of World by Country (2021-2030)
  • Table 54: Vascular Stents Market Analysis in the Middle East (2021-2030)
  • Table 55: Vascular Stents Market Analysis in Africa (2021-2030)
  • Table 56: Vascular Stents Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Vascular Stents Market
  • Figure 3: Vascular Stents Market Analysis in Global (2021-2030)
  • Figure 4: Vascular Stents Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Vascular Stents Market Analysis in Global by Type (2021-2030)
  • Figure 6: Vascular Stents Market Analysis in Global by Material (2021-2030)
  • Figure 7: Vascular Stents Market Analysis in Global by Mode of Delivery (2021-2030)
  • Figure 8: Vascular Stents Market Analysis in Global by End User (2021-2030)
  • Figure 9: Vascular Stents Market Analysis in Global by Geography (2021-2030)
  • Figure 10: Vascular Stents Market Analysis in North America (2021-2030)
  • Figure 11: Vascular Stents Market Analysis in North America by Product Type (2021-2030)
  • Figure 12: Vascular Stents Market Analysis in North America by Type (2021-2030)
  • Figure 13: Vascular Stents Market Analysis in North America by Material (2021-2030)
  • Figure 14: Vascular Stents Market Analysis in North America by Mode of Delivery (2021-2030)
  • Figure 15: Vascular Stents Market Analysis in North America by End User (2021-2030)
  • Figure 16: Vascular Stents Market Analysis in North America by Country (2021-2030)
  • Figure 17: Vascular Stents Market Analysis in the US (2021-2030)
  • Figure 18: Vascular Stents Market Analysis in Canada (2021-2030)
  • Figure 19: Vascular Stents Market Analysis in Mexico (2021-2030)
  • Figure 20: Vascular Stents Market Analysis in Europe (2021-2030)
  • Figure 21: Vascular Stents Market Analysis in Europe by Product Type (2021-2030)
  • Figure 22: Vascular Stents Market Analysis in Europe by Type (2021-2030)
  • Figure 23: Vascular Stents Market Analysis in Europe by Material (2021-2030)
  • Figure 24: Vascular Stents Market Analysis in Europe by Mode of Delivery (2021-2030)
  • Figure 25: Vascular Stents Market Analysis in Europe by End User (2021-2030)
  • Figure 26: Vascular Stents Market Analysis in Europe by Country (2021-2030)
  • Figure 27: Vascular Stents Market Analysis in France (2021-2030)
  • Figure 28: Vascular Stents Market Analysis in Germany (2021-2030)
  • Figure 29: Vascular Stents Market Analysis in the UK (2021-2030)
  • Figure 30: Vascular Stents Market Analysis in Italy (2021-2030)
  • Figure 31: Vascular Stents Market Analysis in Spain (2021-2030)
  • Figure 32: Vascular Stents Market Analysis in Russia (2021-2030)
  • Figure 33: Vascular Stents Market Analysis in Rest of Europe (2021-2030)
  • Figure 34: Vascular Stents Market Analysis in Asia-Pacific (2021-2030)
  • Figure 35: Vascular Stents Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 36: Vascular Stents Market Analysis in Asia-Pacific by Type (2021-2030)
  • Figure 37: Vascular Stents Market Analysis in Asia-Pacific by Material (2021-2030)
  • Figure 38: Vascular Stents Market Analysis in Asia-Pacific by Mode of Delivery (2021-2030)
  • Figure 39: Vascular Stents Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 40: Vascular Stents Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 41: Vascular Stents Market Analysis in China (2021-2030)
  • Figure 42: Vascular Stents Market Analysis in Japan (2021-2030)
  • Figure 43: Vascular Stents Market Analysis in India (2021-2030)
  • Figure 44: Vascular Stents Market Analysis in Australia (2021-2030)
  • Figure 45: Vascular Stents Market Analysis in South Korea (2021-2030)
  • Figure 46: Vascular Stents Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 47: Vascular Stents Market Analysis in Rest of World (2021-2030)
  • Figure 48: Vascular Stents Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 49: Vascular Stents Market Analysis in Rest of World by Type (2021-2030)
  • Figure 50: Vascular Stents Market Analysis in Rest of World by Material (2021-2030)
  • Figure 51: Vascular Stents Market Analysis in Rest of World by Mode of Delivery (2021-2030)
  • Figure 52: Vascular Stents Market Analysis in Rest of World by End User (2021-2030)
  • Figure 53: Vascular Stents Market Analysis in Rest of World by Country (2021-2030)
  • Figure 54: Vascular Stents Market Analysis in the Middle East (2021-2030)
  • Figure 55: Vascular Stents Market Analysis in Africa (2021-2030)
  • Figure 56: Vascular Stents Market Analysis in South America (2021-2030)
  • Figure 57: Market Drivers
  • Figure 58: Market Barriers
  • Figure 59: Market Opportunities
  • Figure 60: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0369

Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2030 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population

The global vascular stents market was valued at USD 13.31 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 21.01 billion by 2030. The increase in demand for vascular stents is predominantly attributed to the growing prevalence of vascular disorders such as atherosclerosis, carotid artery diseases, and peripheral artery diseases, among others. In addition, growing preferences for minimally invasive surgeries among the patient population, growing technological advancement in the product arena, and approval of various vascular stents, among others are some of the factors responsible for driving the global vascular stents market in the forthcoming years.

Vascular Stents Market Dynamics:

The market for vascular stents is gathering momentum at present owing to the rising burden of various vascular disorders among the population across the globe. Vascular disorders or diseases include any condition that affects the blood vessels. Peripheral artery diseases (PAD), carotid artery diseases, coronary artery diseases, stroke are some of the types of vascular disorders which are more prevalent among the worldwide population. For instance, according to the facts revealed by the World Stroke Organization (WSO) in the year 2019, globally, over 80 million people were living who have experienced a stroke.

In addition, as per the Australian Government 2022 data, approximately 38,600 strokes were reported in the country in the year 2018 and about 6.2% of Australian adults (1.2 million) had one or more conditions related to heart, stroke, or vascular diseases in 2017-18. Similar trends are likely to observe in other countries across the globe. Thus, the rising burden of various vascular diseases worldwide is expected to increase the demand for vascular stents thereby augmenting the global vascular stents market growth during the forecast period.

Moreover, rising preferences for minimally invasive surgeries among patients are also anticipated to raise the demand for vascular stents. This is because as compared to bypass surgery, balloon angioplasty and vascular stent placement are much less invasive and relatively low-risk, low-cost procedures.

Additionally, companies receiving reimbursement for their vascular stents products could also increase the market of these devices in the upcoming years as it will raise the adoption of these devices among the patient pool. For instance, in June 2020, SMT (Sahajanand Medical Technologies Pvt Ltd), the Indian market leader in coronary heart stent received the full reimbursement confirmation for its Supraflex and Supraflex Cruz from the Ministry of Health and Public Affairs of France.

Thus, the interplay of all the above-mentioned factors is likely to boost the vascular stents market in the forthcoming years.

However, the risk associated with vascular stents and the stringent regulatory approval process of the product is likely to impede the market growth.

In addition, the unprecedented COVID-19 outbreak has slowed down the global market for Vascular Stents during the initial phases. Nationwide lockdown, canceled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of vascular stents. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the vascular stents market.

Vascular Stents Market Segment Analysis:

Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], EVAR Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon Expandable Stents and Self Expandable Stents), By End-User (Hospitals and Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Vascular Stents type segment, the drug-eluting stents are expected to hold a significant market share during the forthcoming years. The main advantage associated with the drug-eluting stents is that these stents are efficient in reducing the rates of in-stent restenosis after percutaneous coronary intervention (PCI) compared to bare-metal stents (BMS) in stable coronary artery disease. Various researches have demonstrated that Drug-eluting stents (DES) reduce the rate of restenosis by over 70% compared to BMS in native coronary lesions. Thus, at present the DES placement is believed to be preferred by the surgeon during PCI surgery, thereby increasing the demand for the DES vascular stents.

Moreover, the rise in research and development activities by the manufacturers actively developing vascular stents in the market to bring new products in the upcoming years is also expected to fuel the segmental market of vascular stents. For instance, Abbott in June 2020, initiated a clinical trial for its next-generation drug-eluting stent 48mm Study (SPIRIT 48). The purpose of the study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions. Moreover, this clinical investigation will be conducted under an investigational device exemption (IDE) and is intended to support market approval of the ABT NG DES 48 in the United States. The study is expected to get complete by November 2022.

Additionally, approval of various vascular stents at present could also contribute to the segmental market growth. For instance, on October 16, 2020, Biosensors International Group Ltd (Biosensors) was granted a CE Mark for BioFreedom(TM) Ultra, their new drug-coated coronary stent system.

Hence, all the aforementioned factors are projected to drive the segmental growth of the vascular stent market in the forthcoming years.

North America is expected to dominate the overall Vascular Stents Market:

Among all the regions, North America is expected to occupy a major share in the overall vascular stents market during the forecasted period. This is owing to the rising obesity levels, rising hypertension among the population, increase in alcohol consumption, and smoking which often leads to various cardiovascular disorders such as coronary heart and peripheral vascular disorders which require vascular stenting as a treatment. In addition, the growing geriatric population, rapid technological advancements coupled with the increasing healthcare expenditures in the region have spurred the demand for vascular stents.

Further, in the US, as per the report published by the Centers for Disease Control and Prevention in the year 2023, approximately 6.5 million people age 40 and older in the US have Peripheral Artery Diseases (PAD) in the same year.

Also, as per the above-mentioned source, the US obesity prevalence was 42.4% in 2017 - 2018 which tremendously increased from the last decade when it was 30.5% of the total US population. Through various researches, it has been concluded that obesity has an important role in atherosclerosis and coronary artery disease.

Moreover, the presence of key market players and their strategic business activities such as collaboration, approval, and launch of the product, among others are likely to bolster the regional vascular stent market in the upcoming years. For instance, in October 2020, Medtronic received approval from the US Food and Drug Administration (FDA) for its Abre Venous Self-expanding Stent System to treat deep venous obstruction, a medical condition that may limit blood flow from the leg and lead to swelling of the leg and pain when walking.

Hence, the interplay of all the above-mentioned factors is projected to spur the vascular stents market in the region during the forecasted period.

Furthermore, the Asia-Pacific region has the future potential growth for the global vascular stents market. The adoption of a sedentary lifestyle among the population which significantly increases the risk of coronary heart disease, and other vascular disorders is the key driving factor for the vascular stents market. In addition, the rising geriatric population in the region, improving healthcare infrastructure, and rise in disposable income, among others, are some of the factors which make the APAC region the fastest growing market for vascular stents during the forecasted period.

Vascular Stents Market Key Players:

Some of the key market players operating in the Vascular Stents market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others.

Recent Developmental Activities in the Vascular Stents Market:

In August 2020, Boston Scientific Corporation received FDA approval for SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail(TM)), SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System (Over-The-Wire(TM)), and SYNERGY(TM) XD Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail(TM)) is indicated for use in patients who have a narrowing in their coronary arteries and are at high risk for bleeding.

In July 2020, INSPIRON Coronary Sirolimus-Eluting Stent from SCITECH Medical received CE Mark approval.

In May 2020, SMT (Sahajanand Medical Technologies Pvt. Ltd) acquired the structural heart medical device firm Vascular Concepts, providing cutting-edge medical devices for the treatment of arterial diseases.

Key Takeaways from the Vascular Stents Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vascular Stents market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Vascular Stents Market.

Various opportunities available for the other competitor in the Vascular Stents Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Vascular Stents market growth in the coming future?

Target Audience who can be benefited from the Vascular Stents Market Report Study

Vascular Stents providers

Research organizations and consulting companies

Vascular Stents-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Vascular Stents

Various End-users who want to know more about the Vascular Stents Market and the latest technological developments in the Vascular Stents market.

Frequently Asked Questions for the Vascular Stents Market:

1. What are Vascular Stents?

Vascular stents are small tubular scaffolds widely used in the treatment of narrowing of the vessel to prevent acute vessel closure and late restenosis in a variety of vessels such as coronary arteries.

2. What is the market for Global Vascular Stents?

The global vascular stents market was valued at USD 13.31 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 21.01 billion by 2030.

3. What are the drivers for the Global Vascular Stents?

The major factor driving the demand for Vascular Stents is the growing prevalence of vascular disorders such as atherosclerosis, carotid artery diseases, and peripheral artery diseases, among others. Moreover, rising preferences for minimally invasive surgeries among the patient population, increasing technological advancement in the product arena, and approval of various vascular stents, among others are some of the factors responsible for driving the global vascular stents market in the forthcoming years.

4. What are the key players operating in Global Vascular Stents?

Some of the key market players operating in the Vascular Stents market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, and others.

5. Which region has the highest share in the Vascular Stents market?

Among all the regions, North America is expected to occupy a major share in the overall vascular stents market during the forecast period, 2024-2030. This is owing to the rising obesity levels, rising hypertension among the population, increase in alcohol consumption, and smoking which often leads to various cardiovascular disorders such as coronary heart and peripheral vascular disorders which require vascular stenting as a treatment. In addition, the growing geriatric populations, rapid technological advancements coupled with the increasing healthcare expenditures in the region have spurred the demand for vascular stents.

Table of Contents

1.Vascular Stents Market Report Introduction

2.Vascular Stents Market Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vascular Stents Market Key factors analysis

  • 4.1. Vascular Stents Market Drivers
    • 4.1.1. The rising prevalence of various vascular disorders among the population, worldwide
    • 4.1.2. The growing preferences for minimally invasive surgeries
    • 4.1.3. Technological advancement and launches of vascular stents
    • 4.1.4. The rising burden of the geriatric population
  • 4.2. Vascular Stents Market Restraints and Challenges
    • 4.2.1. Risk and complications associated with vascular stents
    • 4.2.2. The stringent regulatory approval process
  • 4.3. Vascular Stents Market Opportunities
    • 4.3.1. Low and middle-income nations have tremendous opportunities for the Vascular Stents market
    • 4.3.2. Opportunities for bioresorbable vascular scaffolds

5. Vascular Stents Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Stents Market

7. Vascular Stents Market layout

  • 7.1. By Product Type
    • 7.1.1. Coronary Stents
    • 7.1.2. Peripheral Stents
      • 7.1.2.1. Carotid Stents
      • 7.1.2.2. Renal Artery Stents
      • 7.1.2.3. Femoral Stents
      • 7.1.2.4. Iliac Stents
      • 7.1.2.5. Other Peripheral stents
    • 7.1.3. EVAR Stent Grafts
      • 7.1.3.1. Abdominal Aortic Aneurysm Stents
      • 7.1.3.2. Thoracic Aortic Aneurysm Stents
  • 7.2. By Type
    • 7.2.1. Bare-metal Stents
    • 7.2.2. Drug-eluting Stents
  • 7.3. By Material
    • 7.3.1. Metal
    • 7.3.2. Polymer
  • 7.4. By Mode of Delivery
    • 7.4.1. Balloon-expandable Stents
    • 7.4.2. Self-expanding Stents
  • 7.5. By End-user
    • 7.5.1. Hospitals
    • 7.5.2. Ambulatory Surgical Centers
  • 7.6. By Geography
    • 7.6.1. North America
      • 7.6.1.1. North America Vascular Stents Market, by Product Type
      • 7.6.1.2. North America Vascular Stents Market, by Type
      • 7.6.1.3. North America Vascular Stents Market, by Material
      • 7.6.1.4. North America Vascular Stents Market, by Mode of Delivery
      • 7.6.1.5. North America Vascular Stents Market, by End User
      • 7.6.1.6. North America Vascular Stents Market, by Country
      • 7.6.1.6.1. United States
      • 7.6.1.6.2. Canada
      • 7.6.1.6.3. Mexico
    • 7.6.2. Europe
      • 7.6.2.1. Europe Vascular Stents Market, by Product Type
      • 7.6.2.2. Europe Vascular Stents Market, by Type
      • 7.6.2.3. Europe Vascular Stents Market, by Material
      • 7.6.2.4. Europe Vascular Stents Market, by Mode of Delivery
      • 7.6.2.5. Europe Vascular Stents Market, by End User
      • 7.6.2.6. Europe Vascular Stents Market, by Country
      • 7.6.2.6.1. France
      • 7.6.2.6.2. Germany
      • 7.6.2.6.3. United Kingdom
      • 7.6.2.6.4. Italy
      • 7.6.2.6.5. Spain
      • 7.6.2.6.6. Russia
      • 7.6.2.6.7. Rest of Europe
    • 7.6.3. Asia-Pacific
      • 7.6.3.1. Asia-Pacific Vascular Stents Market, by Product Type
      • 7.6.3.2. Asia-pacific Vascular Stents Market, by Type
      • 7.6.3.3. Asia-Pacific Vascular Stents Market, by Material
      • 7.6.3.4. Asia-Pacific Vascular Stents Market, by Mode of Delivery
      • 7.6.3.5. Asia-Pacific Vascular Stents Market, by End User
      • 7.6.3.6. Asia-Pacific Vascular Stents Market, by Country
      • 7.6.3.6.1. China
      • 7.6.3.6.2. Japan
      • 7.6.3.6.3. India
      • 7.6.3.6.4. Australia
      • 7.6.3.6.5. South Korea
      • 7.6.3.6.6. Rest of Asia Pacific
    • 7.6.4. Rest of the World (RoW)
      • 7.6.4.1. RoW Vascular Stents Market, by Product Type
      • 7.6.1.2. RoW Vascular Stents Market, by Type
      • 7.6.1.3. RoW Vascular Stents Market, by Material
      • 7.6.4.4. RoW Vascular Stents Market, by Mode of Delivery
      • 7.6.4.5. RoW Vascular Stents Market, by End User
      • 7.6.4.6. RoW Vascular Stents Market, by Region
      • 7.6.4.6.1. Middle East
      • 7.6.4.6.2. Africa
      • 7.6.4.6.3. South America

8. Vascular Stents Global Company Share Analysis - Key 3-5 Companies

9. Vascular Stents Company and Product Profiles

  • 9.1. Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Abbott
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. BIOTRONIK SE & Co. KG
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. B. Braun Melsungen AG
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Terumo Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. eucatech AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. MicroPort Scientific Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Meril Life Sciences Pvt. Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Vascular Concepts (SMT)
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. W. L. Gore & Associates, Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Becton, Dickinson and Company.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. ENDOLOGIX LLC.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Biosensors International Group, Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Lombard Medical
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Translumina GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. JOTEC GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. iVascular
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Cordis
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Cook
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us